हिन्दी
English
मराठी
বাংলা
தமிழ்
മലയാളം
ગુજરાતી
తెలుగు
ಕನ್ನಡ
ଓଡ଼ିଶା
Business
Tech
World
Health
NEWS
VIDEOS
PHOTOS
Web Stories
LIVE TV
GO
Latest
India
Ahmedabad
Bengaluru
Chennai
Hyderabad
Kolkata
Mumbai
Pune
Cricket
Success Story
Entertainment
Hollywood
Music
Bollywood
Television
Regional
Movie Review
Lifestyle
Relationship
Travel
Food & Recipes
Fashion
Culture
Spirituality
Business
Economy
Markets
Companies
Real Estate
International Business
Personal Finance
Automobile
Technology
Gadgets
Gaming
Internet & Social Media
Apps
Mobiles
World
Asia
Africa
Americas
Australia-Oceania
Europe
Auto
Mobility
Viral
Diabytes
Fables of Facades
Archived Videos
Newsletter
Fables of Facades
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Advertisement
X
News
Pharmaceutical Industries
Pharmaceutical Industries News
Lupin Pharmaceuticals
17 Aug 2016
Lupin Pharmaceuticals is India's most reputed pharma brand; Sun Pharma second
Mumbai-based Lupin Pharmaceuticals is India`s most reputed pharmaceutical brand, said a report by Bluebytes, a leading media-analytics company on Wednesday.
NPPA
27 Jun 2016
42 essential medicines to be cheaper by up to 15%: NPPA
Prices of 42 essential medicines used in treatment of various ailments including tuberculosis, cancer, cardiac diseases, asthma, epilepsy, rheumatoid arthritis and depression have been capped by the government, reducing their cost by up to 15 percent.
FDI
20 Jun 2016
FDI up to 74% in brownfield pharma under automatic route
The government today allowed up to 74 percent foreign direct investment in the existing pharmaceutical companies through automatic route, with an aim to promote the sector.
Kiran Mazumdar-Shaw
06 Apr 2016
Give exemption from drug price control for 5 years: Mazumdar-Shaw
Seeking a five-year exemption from drug price control, Biocon CMD Kiran Mazumdar-Shaw Wednesday asked the government to refrain from 'ad hoc' measures so as to enable the pharma sector to build scale to be globally competitive.
Pfizer
15 Mar 2016
After Pfizer, HC grants relief to Abbott and Macleods
Pharma majors Abbott Healthcare and Macleods Pharmaceuticals Tuesday got interim relief from the Delhi High Court which stayed till March 21 Government's decision banning sale of certain combination medicines of the two companies.
Cipla Limited
10 Feb 2016
Cipla Q3 net profit rises 4.68% to Rs 343.20 crore
Pharmaceutical firm Cipla Ltd Wednesday reported 4.68 percent increase in its consolidated net profit at Rs 343.20 crore in the third quarter ended December 2015.
Medicine prices
07 Feb 2016
'Withdrawing customs duty may lead to hike in medicine prices'
The government's move to withdraw customs duty exemption on imports of around 74 drugs would help in local production of bulk drugs and thereby create demand for the local production but it may also lead to rise in prices for these medicines.
India
29 Nov 2015
Govt in talks with various markets to accept Indian drug norms
India is nudging various semi-regulated markets like Myanmar and Kenya to accept its drug standards, instead of the US or British norms, a move aimed at helping many Indian drug makers to save cost on upgrading to international standards.
Dr Reddy's Laboratories
26 Nov 2015
USFDA gives Dr Reddy's addl time to respond to warning letter
Dr Reddy's Laboratories Ltd (DRL) Thursday said the USFDA has extended the time-frame for replying to the warning letter issued to the company by about two weeks to December 7.
Dr Reddy's Laboratories
29 Oct 2015
Dr Reddy's Lab Q2 net profit rises 26% to Rs 722 crore
Aided by good sales growth coupled with new product launches, drug major Dr Reddy's Laboratories Thursday reported a 25.74 percent jump in consolidated net profit at Rs 721.89 crore for the second quarter ended September 30.
Novartis AG
28 Oct 2015
Novartis gets USFDA warning letter for two plants in India
Sandoz, the generic drug arm of Swiss drug major Novartis, has received a warning letter from the US health regulator for violations of current good manufacturing practice (cGMP) norms at its two plants in Western India.
Lupin
26 Oct 2015
Lupin appoints Martin Mercer as head of Latin American biz
Drug major Lupin Monday appointed Martin Mercer as President of its Latin American business with immediate effect.
Cipla
20 Oct 2015
Cipla's Indore plant under USFDA scanner over norms violations
Pharmaceutical major Cipla's shares dropped by 2.13 percent Tuesday amid speculation that the company's Indore plant has come under the scanner of US health regulator for manufacturing norms violations.
Pharmaceutical Industries
11 Oct 2015
Govt to commission study on impact of FDI in pharma
The government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies in view of concerns expressed on the issue by a Parliamentary panel.
Sun Pharmaceutical Industries
29 Sep 2015
Sun Pharma makes tender offer to acquire InSite Vision
Drug major Sun Pharmaceutical Industries has made a tender offer to acquire US-based eyecare firm InSite Vision for USD 0.35 per share in cash.
Glenmark Pharmaceuticals
22 Sep 2015
Glenmark Pharma eyes US biz to be strong growth driver
Glenmark Pharmaceuticals Tuesday said it is looking at strong growth in the US market and developing a pipeline of innovative products to offset weakness in emerging markets.
pharma exports
18 Aug 2015
Govt assures all help to boost pharma exports
Government Tuesday assured the pharma industry of "every possible help" in resolving its issues related to exports and said efforts would be made to expedite work on different proposals to realise the full potential of the sector.
India
05 Aug 2015
India defers FTA talks with EU over ban of 700 pharma products
Expressing disappointment and concern over the EU banning sale of around 700 pharma products clinically tested by GVK Biosciences, India has deferred the talks with the European Union on the proposed free trade agreement.
SRL Diagnostics
02 Aug 2015
SRL lines up Rs 100 crore to add 100 labs by 2016-end
Leading laboratory network SRL Diagnostics is planning to invest around Rs 100 crore to add 100 labs across the country by the end of 2016 as part of its expansion plan.
Pharmaceutical Industries
28 Jul 2015
Hikma buys US generic drugmaker Roxane for $2.65bn
London-listed pharmaceuticals firm Hikma on Tuesday bought US generic drugs company Roxane from German peer Boehringer Ingelheim for $2.65 billion (2.40 billion euros) in the sector`s latest rapid round of consolidation.
601173
1
4
Loading...
Trending news
DNA Video
DNA: Anmol Bishnoi Seeks Asylum in the U.S.
DNA Video
DNA: Adani Case - Corruption Allegations Rock Indian Markets
DNA Video
DNA: Were Muslims Stopped from Voting in UP By-Elections?
DNA Video
DNA: Who Did Maharashtra’s Muslims Vote For?
DNA Video
DNA: Russia-Ukraine Conflict Escalates Amid Missile Attacks
DNA Video
DNA: The Beer-Loving Buffalo Stuck in Bihar!
DNA Video
DNA: Akhilesh and the Burqa Controversy in UP Elections
DNA Video
DNA: Is the Opposition to ‘Bantenge To Katenge’ Part of a Larger Plan?
DNA Video
DNA: RSS Master Plan: From Maharashtra to UP
DNA Video
DNA: Bengal’s Waqf Property Controversy
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
×
Cookies Settings
Reject
Accept Cookies
NEWS ON ONE CLICK